- Genomics - Global - World Health Organization (WHO)
Genomics is evolving rapidly, and its potential impact for the future of human health cannot yet be known Human genomics knowledge and technologies provide new ways to prevent and manage many diseases, and opportunities to achieve global public health goals Genomic knowledge of other organisms contributes to the understanding of human health and diseases, the interconnectedness across
- WHO releases new principles for ethical human genomic data collection . . .
The World Health Organization (WHO) has issued a set of principles for the ethical collection, access, use and sharing of human genomic data Created with guidance from the WHO Technical Advisory Group on Genomics (TAG-G) and other international experts, these principles establish a global approach to help protect individual rights, promote equity and foster responsible collaboration in
- WHO global genomic surveillance strategy for pathogens with pandemic . . .
Global genomic surveillance strategy for pathogens with pandemic and epidemic potential, 2022–2032 The Strategy provides a high-level unifying framework to leverage existing capacities, address barriers and strengthen the use of genomic surveillance in the detection, monitoring and response to public health threats Genomic surveillance is part of the broader surveillance and laboratory
- News - World Health Organization (WHO)
Abortion: Safety Accessing and implementing GCF readiness funds Addictive behaviours: Gaming disorder Adolescent health and development Adolescent sexual and reproductive health Ageing: Ageism Ageing: Global population Air pollution: Personal interventions and risk communication Air pollution: Reducing short-lived climate pollutants Antibiotic resistance: Why vaccination is important
- The essential task of strengthening genomic surveillance: WHO in . . .
The crucial role of effective genomic surveillanceWith the COVID-19 pandemic progressing, genomic surveillance, conducted in an efficient way, is essential to inform us of circulating viruses and response measures required The sequencing of representative samples continuously collected in a standardized approach from patients meeting influenza-like illness, acute respiratory infection, and
- Human genome editing - World Health Organization (WHO)
In December 2018, WHO established a global, multi-disciplinary Expert Advisory Committee to examine the scientific, ethical, social and legal challenges associated with human genome editing (somatic, that is, non-heritable; germline, involving in vitro studies on early embryos, gametes or their precursors; and heritable, where embryos subject to genome editing are used to establish pregnancies
- Guidance for human genome data collection, access, use and sharing
The WHO’s new document outlines a comprehensive set of globally applicable principles designed to guide stakeholders in the responsible collection, use, and sharing of human genome data This document serves as a key resource to navigate complex issues surrounding data governance, with the aim of fostering transparency, promoting equity, and safeguarding individual and collective rights
- A milestone in public health and disease surveillance: Fiji launches . . .
A newly established in-country laboratory now provides this critical capability locally, saving time and costs associated with international specimen referral “The ability to conduct genomic sequencing in-country marks a major step forward in public health,” said Sophie Genay-Diliautas, Deputy WHO Representative to the South Pacific during
|